ASMB (STOCKS)
Assembly Biosciences, Inc
$26.520000
-0.960000 (-3.49%)
Prev close: $27.480000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jason A. Okazaki
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $439.63M
- Employees
- 73
- P/E (TTM)
- -5.72
- P/B (TTM)
- 2.38
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.72 | $-0.79 | +0.0702 | +8.88% |
|
Jun 2025 (Q2)
|
$-1.33 | $-1.39 | +0.0623 | +4.47% |
|
Mar 2025 (Q1)
|
$-1.17 | $-1.63 | +0.4620 | +28.31% |
|
Dec 2024 (Q4)
|
$-1.57 | $-2.08 | +0.5108 | +24.55% |
Financial Statements
| Revenues | $37.19M |
| Benefits Costs and Expenses | $75.81M |
| Costs And Expenses | $75.81M |
| Nonoperating Income/Loss | $4.83M |
| Operating Expenses | $80.64M |
| Research and Development | $61.84M |
| Other Operating Expenses | $18.80M |
| Operating Income/Loss | -$43.45M |
| Income/Loss From Continuing Operations After Tax | -$38.55M |
| Income/Loss From Continuing Operations Before Tax | -$38.62M |
| Income Tax Expense/Benefit | -$76.00K |
| Net Income/Loss | -$38.55M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$38.55M |
| Net Income/Loss Available To Common Stockholders, Basic | -$38.55M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$4.60 |
| Diluted Earnings Per Share | -$4.60 |
| Basic Average Shares | 28,025,107 |
| Diluted Average Shares | 9,478,550 |
| Assets | $240.00M |
| Current Assets | $236.81M |
| Cash | $232.60M |
| Other Current Assets | $4.21M |
| Noncurrent Assets | $3.19M |
| Fixed Assets | $229.00K |
| Other Non-current Assets | $2.96M |
| Liabilities | $57.30M |
| Current Liabilities | $53.38M |
| Accounts Payable | $1.68M |
| Wages | $5.05M |
| Other Current Liabilities | $46.64M |
| Noncurrent Liabilities | $3.92M |
| Equity | $182.70M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $182.70M |
| Liabilities And Equity | $240.00M |
| Net Cash Flow From Operating Activities | -$55.74M |
| Net Cash Flow From Operating Activities, Continuing | -$55.74M |
| Net Cash Flow From Investing Activities | -$141.39M |
| Net Cash Flow From Investing Activities, Continuing | -$141.39M |
| Net Cash Flow From Financing Activities | $191.21M |
| Net Cash Flow From Financing Activities, Continuing | $191.21M |
| Net Cash Flow | -$5.92M |
| Net Cash Flow, Continuing | -$5.92M |
| Comprehensive Income/Loss | -$38.48M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$38.48M |
| Other Comprehensive Income/Loss | -$19.33M |